Chordate Medical Holding
0.99 SEK
Less than 1K followers
CMH
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-8.15 %
-74.17 %
-81.96 %
-83.74 %
-87.42 %
-91.14 %
-99.53 %
-99.29 %
-99.94 %
Chordate Medical Holding is a medical technology company that has developed, patented and CE-marked Ozilia® Migraine, a neuromodulatory and drug-free treatment technique for chronic migraine and chronic rhinitis. The treatment has proven efficacy according to a clinical study and is marketed in selected markets in the EU and the Middle East. The company is headquartered in Kista.
Read moreMarket cap
2.68M SEK
Turnover
-
Revenue
660K
EBIT %
-4,159.09 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27/2
2026
Annual report '25
All
Press releases
3rd party
ShowingAll content types
Chordate Medical terminates the liquidity guarantee for the common share
Kommuniké från extra bolagsstämma i Chordate Medical Holding AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools